Penrhos Bio raise £1m Seed funding to accelerate development of the Remora™️ technology, and is joined as an investment partner by Eos Advisory.
Penrhos Bio has secured the second tranche of its £1m Seed funding round, and is pleased to welcome Eos Advisory as investment partners. This investment, including the first tranche in 2021, takes the business through to its Series A raise in 2023, and accelerates our business development pipeline.
for the press release see:
Scottish-based cleantech business Penrhos Bio has raised £3 million in Series A funding supported by Innova Partnerships.
Novarum DX, the mobile software arm of BBI Solutions, has been bought out by a small group of investors led by Innova Partnerships and the existing management.
The deal should let the company build on its lateral flow test customer base and extend into adjacent markets.
Biotangents launched the AmpliSpec LAB Mastitis device in an event at the Moredun Research Institute, close to its headquarters at the Pentlands Science Park near Edinburgh. The disease is estimated to cost the global dairy industry around £25 billion a year.
AmpliSpec™ LAB BVDV is Biotangents’ first next generation molecular diagnostic assay for the detection of BVDV in cattle. Its unique design combines LAMP technology, lyophilised bead technology and Biotangents’…
Cellexus have partnered with Castleford-based Verder Liquids to provide pumps to be used for the acid / base pump, included as standard with the CellMaker Plus and Low Flow bioreactor systems.
First product launched with Remora® technology to control harmful biofilms at IDS dental trade fare, Germany.
Contact: info@innovapartnerships.com
Terms and Conditions • Web Terms of Use ©2023 Innova Partnerships, All Rights reserved